Discover why income-focused investors are eyeing HQH with its high dividend yield and discounted NAV, despite sector-specific ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results tomorrow afternoon. Here’s what to look for.

Illumina's revenue has stagnated or declined for several years now, and its total sales for 2024 were $4.3 billion, down from ...

The maker of Yankee Candle and Sharpie pens said volumes fell and foreign exchange rates were a headwind in the fourth quarter. The sports-car maker warned that profits will be hurt this year as it ...

The monthly jobs report showed hiring slowed in January and the U.S. created fewer jobs than economists expected. The unemployment rate ticked down to 4%. Follow along for live updates on stocks and ...

Amgen's dividend yield remains attractive, with a moderate payout ratio and strong free cash flow. Click here to see why AMGN ...

AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.

Uncertainty about U.S. trade tariffs and persistent portfolio outflows have hurt the rupee over the last two months and made ...